SLS Overview
Upcoming Projects (SLS)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (SLS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (SLS)
-
Phase 3 final endpoint of NeuVax (E75) for low-to-intermediate HER2+ breast cancer is expected to be reached in 2018 - Terminated
Tickers: SLS, GALE
Occurred on: Jun 01, 2018
Strategic Initiatives (SLS)
-
Don’t see a strategic initiative related to the company you care about? Create your own!